Upadacitinib
Spécifications
1310726-60-3Numéro CAS
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamideNom IUPAC
C17H19F3N6OFormule chimique
380.4 g/molMasse molaire
Upadacitinib; 1310726-60-3; ABT-494; Upadacitinib anhydrous; 4RA0KN46E0; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; DTXSID901027919; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; upadacitinibum; RefChem:57163; L04AA44; DTXCID401513480; (3S,4R)-3-ethyl-4-(1,5,7,10-tetraazatricyclo(7.3.0.0^(2,6))dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; Rinvoq; (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; ABT 494; UNII-4RA0KN46E0; C17H19F3N6O; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; Upadacitinib [USAN]; Upadacitinib (Standard); UPADACITINIB [MI]; Upadacitinib, ABT-494; Upadacitinib (USAN/INN); UPADACITINIB [INN]; Upadacitinib [USAN:INN]; Upadacitinib (ABT-494); UPADACITINIB [WHO-DD]; GTPL9246; orb1299762; SCHEMBL9991056; CHEMBL3622821; WYQFJHHDOKWSHR-MNOVXSKESA-N; GLXC-10425; UPADACITINIB [ORANGE BOOK]; EX-A1628; BDBM50503287; EBC-26865; HY-19569R; s8162; AKOS030567686; CS-6150; DB15091; ABBV-599 COMPONENT UPADACITINIB; NCGC00588874-01; AC-30326; AS-56379; DA-78788; FA166721; HY-19569; NS00133778; T7503; C72237; D10994; F797290; Q27074125; Z2831495606; (3S,4R)-3- Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide; 1831899-72-9; ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; rel-(3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamideSynonymes
Produits contenant Upadacitinib
CHEMISTRY Discover Molecule InsightsUpadacitinib(Semihydrate)Upadacitinib TabletsUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUPADACITINIB
Page 1 sur 3
Services liés à Upadacitinib
Entreprises vendant Upadacitinib
HR
Hangzhou Royall Import & Export Co.,LtdChinaJM
Jiangsu Magic Biotechnology Co., LtdChinaCP
CHENGHUI PHARMACEUTICAL GROUP LTDChinaSI
Sinoway Industrial Co.Ltd.ChinaSI
Shanghai IntVal Chemicals Co., LtdChinaRG
ROUNDCARE GROUPChinaHH
HANGZHOU HONGQIN PHARMTECH CO.,LTDChinaSG
Sichuan Gowell Pharmaceutical Co., Ltd.ChinaAH
Anhui Haikang Pharmaceutical Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChinaPage 1 sur 2